Search

Welcome to NRG Oncology!

Welcome to the NRG Oncology Web site! This resource serves to provide current information about NRG Oncology’s exciting research future and the latest updates about plans to support our clinical trial endeavors. We invite you to check back often to learn “what’s new.”

Who We Are

NRG Oncology brings together the unique and complementary research areas of the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG). NRG Oncology builds upon our more than 150 years of cumulative research experience to conduct practice defining, multi-institutional clinical trials resulting in the improved survival and quality of life of patients with cancer. NRG Oncology has been awarded a grant by the National Cancer Institute (NCI) as a member of the NCI National Clinical Trials Network (NCTN).

Click here to access all weekly broadcasts


Protocol Table Survey

Have you used the NRG Oncology protocol table under the Clinical Trials tab? If so, please fill out our brief survey to give us feedback on what you like about the table and how we can improve.

NCORP Badge English636404806468909532



NRG Oncology is proud to be an 
active participant of Cancer Moonshot.

NCORP

Learn about the leaders and plans for NRG Oncology's NCORP Research Base.

 

NRG Oncology
Four Penn Center, 1600 JFK Blvd, Suite 1020, Philadelphia, PA 19103
267-519-6630
Contact Us

To receive the NRG Oncology Newsletter and occasional eNews announcements and press releases, please email info@nrgoncology.org

What’s New

Dr. Chakravarti Selected to Serve on NCI Advisory Board of Scientific Counselors Read more

Dr. Felix Feng Selected as the New NRG Oncology Genitourinary Cancer Committee Chair Read more

Drs. Fisher & Wolmark receive SSO 2018 Charles M. Balch, MD Distinguished Service Award. Read more

NRG Oncology/RTOG 0126: Higher-Dose Radiotherapy Lowers Risk of Recurrence but Does Not Improve Survival for Men with Prostate Cancer Read more

Project Team Member Application for Radium-223 now posted. Forms are due by March 22, 2018. Read more

NRG Oncology NCORP PI, Dr. Bruner, Appointed as NCI Global Health Read more Read more

NRG Oncology Appoints NCORP Investigator, Matthew Hudson, as Cancer Care Delivery Research  Committee Co-Chair Read more

Aghajanian Appointed as NRG Oncology Gynecologic Cancer Committee Chair Read more

Press Release Issued Regarding NRG Oncology's New Executive Director, Kati Stoermer Read more

NRG Oncology Newsletter Volume 1, 2018 is now available! Read more

Trastuzumab does not negatively impact cardiac function for women with breast cancer in long-term follow-up Read more

New threat for those who publish: PREDATORY JOURNALS.  Read about this evolving issue under "Publications: Publication Updates" Read more

Antiangiogenesis Therapy Improves Overall Survival for Patients with Advanced Cervical Carcinoma Read more

Knowledge-Based Planning Model Aids Clinical Trial Outcomes Read more

MGMT Promoter Predicts Overall Survival for Patients with Anaplastic Astrocytoma Read more

Phase III trial confirms pelvic radiation as standard of care for high-risk, early-stage endometrial cancer Read more

Nomograms Developed and Validated for Patients with Squamous Cell Carcinoma of Larynx by NRG Oncology Read more

Results of NRG Oncology SBRT Comparison Trial for Lung Cancer Patients Consistent after Long-term Follow-up Read more

First Study of Its Kind Depicts Benefits of Brachytherapy for Patients with recurrent Prostate Cancer after EBRT Read more

Results Robert S. Mannel, MD Appointed as an NRG Oncology Group Chairman. Read more

NRG Oncology Newsletter Volume 4 2017 is now available! Read more

The NRG Oncology Biobank locations at the MD Anderson Cancer Center and Baylor University in Houston are now operational and able to receive USPS and express mail shipments. Effective immediately, please resume normal shipping procedures according to protocol requirements.


Copyright 2018 by NRG Oncology